NeuroBo Pharmaceuticals Inc. (NRBO) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NeuroBo Pharmaceuticals I...

    NASDAQ: NRBO · Real-Time Price · USD
    2.36
    null (null%)
    At close: Nov 27, 2024, 10:00 PM

    NeuroBo Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -4.58 -1.5 -0.13 -1.85
    PEG Ratio
    		 -0.1 0.02 0.00 0.03
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 15.94 1.12 0.08 1.93
    P/FCF Ratio
    		 -5.12 -1.73 -0.16 -1.87
    P/OCF Ratio
    		 -5.12 -1.74 -0.16 -1.87
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.02 0.01 n/a 0.00
    Quick Ratio
    		 1.94 3.78 2.85 7.69
    Current Ratio
    		 1.94 3.78 2.85 7.69
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -8.96 n/a
    Return on Equity
    		 -3.48 -0.75 -0.64 -1.05
    Return on Assets
    		 -1.7 -0.55 -0.42 -0.91
    Return on Invested Capital
    		 -3.57 -0.94 -0.9 -1.04
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist